ライフサイエンスコーパス: TURP

1 TURP and ThuVARP were equivalent for urinary symptom imp

2 TURP explained much of the observed increase in overall

3 TURP has declined due to medical therapy, but transcends

4 TURP is still rightly the dominant, most widely performe

5 TURP was superior for Qmax (mean 23.2 mL per s for TURP

6 TURP-detected cases prior to 1986 were calculated using

7 between 1986 and 1993 to determine whether a TURP occurred sufficiently close to the time of a prosta

8 e considered as a treatment option alongside TURP and medical management.

9 provement (IPSS) 12-months post-surgery, and TURP was superior for Qmax.

10 ally detected significant prostate cancer at TURP may have declined, whereas TURP for prostate cancer

11 Equivalence was shown for IPSS (mean 6.3 for TURP and 6.4 for ThuVARP; adjusted difference in means 0

12 ng inpatient hospitalization (range: 61% for TURP to 88% for total hip arthroplasty), and are thus mi

13 as superior for Qmax (mean 23.2 mL per s for TURP and 20.2 mL per s for ThuVARP; adjusted difference

14 We aimed to investigate TURP versus ThuVARP in men with lower urinary tract symp

15 The authors identified the effect of TURP-detected prostate cancer on the observed incidence

16 The declining influence of TURP on prostate cancer incidence is likely to have cont

17 The changing role of TURP in detecting prostate cancer is attributed to chang

18 Residents are disturbingly short of TURP exposure, consequently experiencing more complicati

19 ge Survey) by estimates of the proportion of TURPs resulting in a prostate cancer diagnosis (from Med

20 410 men were randomly assigned to ThuVARP or TURP, 205 per study group.

21 t the point of surgery to receive ThuVARP or TURP.

22 s a technique with suggested advantages over TURP, including reduced complications and hospital stay.

23 f a transurethral resection of the prostate (TURP) as implant candidates, may reduce urethral toxicit

24 ansurethral resection (TUR) of the prostate (TURP) has dominated symptomatic benign prostatic hyperpl

25 Transurethral resection of the prostate (TURP) has long been held as the gold standard for treatm

26 of transurethral resection of the prostate (TURP) in recent decades has had a large effect on prosta

27 f a transurethral resection of the prostate (TURP) in the UK who were managed conservatively.

28 Transurethral resection of the prostate (TURP) is the standard operation for benign prostatic obs

29 t a transurethral resection of the prostate (TURP) within 2 years of implantation.

30 or transurethral resection of the prostate (TURP; trial 2) to compare four sessions with a therapist

31 We analysed recent TURP publications, with emphasis on durability, morbidit

32 ve office-based alternative to both standard TURP and medical therapy in the treatment of bladder out

33 answers compared to traditional techniques (TURP, simple prostatectomy).

34 d time to death from prostate cancer for the TURP cohort.

35 In the TURP cohort, the CCP score was the most important variab

36 91 (45%) of 204 patients in the TURP group and 96 (47%) of 203 patients in the ThuVARP g

37 ndirect method that involved multiplying the TURP procedure rate in the general population (from the

38 tices as a suitable treatment alternative to TURP and medical therapy.

39 ound its place as one of the alternatives to TURP.

40 med transurethral resection of bladder tumor-TURP seems oncologically acceptable (in selected cases);

41 Patients (n = 10) undergoing TURP were prospectively consented based on their having

42 Centres used their usual TURP procedure (monopolar or bipolar).

43 te cancer at TURP may have declined, whereas TURP for prostate cancer may indicate the need for earli